Anticancer compounds for B cell cancer therapy targeting cellular stress response

(The Wistar Institute) Wistar and collaborators from the University of Notre Dame are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the development of multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and lymphoma.
Source: EurekAlert! - Biology - Category: Biology Source Type: news